Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion.
Breccia M, Pregno P, Spallarossa P, Arboscello E, Ciceri F, Giorgi M, Grossi A, Mallardo M, Nodari S, Ottolini S, Sala C, Tortorella G, Rosti G, Pane F, Minotti G, Baccarani M. Breccia M, et al. Among authors: ottolini s. Ann Hematol. 2017 Apr;96(4):549-558. doi: 10.1007/s00277-016-2820-x. Epub 2016 Sep 30. Ann Hematol. 2017. PMID: 27686083 Review.
Through the looking glass.
Ottolini SR. Ottolini SR. Ann Emerg Med. 2009 Dec;54(6):841-2. doi: 10.1016/j.annemergmed.2009.03.029. Ann Emerg Med. 2009. PMID: 19942070 No abstract available.
Body mass reduction markedly improves muscle performance and body composition in obese females aged 61-75 years: comparison between the effects exerted by energy-restricted diet plus moderate aerobic-strength training alone or associated with rGH or nandrolone undecanoate.
Sartorio A, Maffiuletti NA, Agosti F, Marinone PG, Ottolini S, Lafortuna CL. Sartorio A, et al. Among authors: ottolini s. Eur J Endocrinol. 2004 Apr;150(4):511-5. doi: 10.1530/eje.0.1500511. Eur J Endocrinol. 2004. PMID: 15080781 Clinical Trial.
11 results